Skip to main content
. 2024 Jun 12;33(172):230266. doi: 10.1183/16000617.0266-2023

FIGURE 2.

FIGURE 2

Innovative therapeutic approaches targeting innate immunity during respiratory tract infections (RTIs). Several strategies have evolved targeting reduced interferon (IFN) production, innate mucosal immune populations, trained innate immunity and excessive inflammation during RTIs. BCG: bacille Calmette–Guérin; MF: macrophage; NK: natural killer.